Teclistamab Shows ' Promising ' Activity in R/R Multiple Myeloma Teclistamab Shows ' Promising ' Activity in R/R Multiple Myeloma

Investigational drug teclistamab is ' a promising new, off-the-shelf, T-cell redirecting therapy targeting BCMA for patients with relapsed or refractory MM, ' say researchers.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news